FENNEC PHARMACEUTICALS INC. - COM (FENC)

Historical Portfolio Holders from Q3 2017 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
14.3 M
Holdings value Q1 2024
$159 M
Value change Q1 2024
-$5.97 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
61
Number of buys Q1 2024
34
Number of sells Q1 2024
-20
Average buys Q1 2024 %
+0.001%
Average sells Q1 2024 %
0%
CUSIP
31447P100
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 14.3 M $159 M -$5.97 M $11.12 61
2023 Q4 14.9 M $167 M +$8.15 M $11.22 53
2023 Q3 14.2 M $107 M +$1.44 M $7.51 53
2023 Q2 14 M $124 M +$9.26 M $8.83 52
2023 Q1 13 M $108 M +$4.62 M $8.32 51
2022 Q4 12.5 M $120 M +$10.7 M $9.60 41
2022 Q3 10.4 M $83.9 M +$2.92 M $8.10 30
2022 Q2 112 $1 K -$14 K $8.93 1
2022 Q1 11.4 M $64 M +$541 K $5.60 22
2021 Q4 11.3 M $49.9 M -$2.27 M $4.40 24
2021 Q3 11.6 M $110 M -$3.02 M $9.42 30
2021 Q2 12 M $87.7 M -$14.2 M $7.29 36
2021 Q1 14.3 M $89 M -$487 K $6.21 46
2020 Q4 14.5 M $108 M +$5.06 M $7.45 47
2020 Q3 13.8 M $83.8 M -$965 K $6.06 50
2020 Q2 13.8 M $116 M +$37.8 M $8.35 51
2020 Q1 9.46 M $56.2 M +$983 K $5.94 25
2019 Q4 9.29 M $60.3 M -$39.1 K $6.48 24
2019 Q3 8.46 M $40.7 M -$1.96 M $4.81 20
2019 Q2 8.99 M $35.9 M -$3.1 M $4.00 24
2019 Q1 9.58 M $46.5 M -$672 K $4.85 40
2018 Q4 9.7 M $61.9 M +$1.84 M $6.38 39
2018 Q3 9.43 M $77.4 M -$275 K $8.20 40
2018 Q2 9.39 M $98.1 M +$18.2 M $10.44 41
2018 Q1 7.62 M $92.2 M +$5.66 M $12.09 20
2017 Q4 6.95 M $69.6 M +$18 M $9.97 13
2017 Q3 5.21 M $57.7 M +$57.7 M $11.08 9